Catalyst Wire Dossier Catalyst Wire Dossier

Aztreonam lysine for inhalation

aztreonam lysine · Gilead Sciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aztreonam lysine for inhalation, covering 2015-11-26 to 2015-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) [Phase 4]

See pricing